Microglia-mediated inflammatory cytokine production

Microglia-mediated inflammatory cytokine production is a complex biological process where the resident immune cells of the central nervous system (CNS) respond to pathological stimuli by secreting pro-inflammatory signaling molecules (Glass et al., 2010, Cell). Upon activation by damage-associated molecular patterns (DAMPs) or pathogen-associated molecular patterns (PAMPs), microglia utilize various receptors such as Toll-like receptor 4 (TLR4) and P2X7 to trigger intracellular cascades, notably the NLRP3 inflammasome (Heneka et al., 2013, Nature). This results in the release of potent cytokines including Interleukin-1 beta (IL-1β), Tumor Necrosis Factor-alpha (TNF-α), and Interleukin-6 (IL-6). While initially a protective response to injury or infection, chronic or dysregulated cytokine production is a hallmark of neurodegenerative diseases, contributing to neuronal damage and cognitive decline. Therapeutic strategies often focus on specific molecular components within this process, such as the NLRP3 inflammasome or specific cytokine receptors, to dampen neuroinflammation without compromising essential microglial functions like phagocytosis and tissue repair (Garrido-Mesa et al., 2013, Br J Pharmacol). Furthermore, the modulation of this process is being explored in the context of psychiatric disorders and chronic pain, where microglial overactivity is implicated in synaptic dysfunction (Paolicelli et al., 2011, Science).

Other names

Microglial neuroinflammationMicroglial activationPro-inflammatory cytokine release from microglia

Inhibition of microglial activation, blockade of pattern recognition receptors (PRRs), inhibition of the NLRP3 inflammasome, and neutralization of secreted pro-inflammatory cytokines.